TG THERAPEUTICS, INC. (TGTX) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $100.71M | +161.7% |
| 2024 | $38.49M | +172.4% |
| 2023 | $14.13M | +5232.5% |
| 2022 | $265.0K | -66.5% |
| 2021 | $790.0K | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $100.71M | +161.7% |
| 2024 | $38.49M | +172.4% |
| 2023 | $14.13M | +5232.5% |
| 2022 | $265.0K | -66.5% |
| 2021 | $790.0K | — |